This is a stark representation of the general immune impairment in these individuals, which has been in part attributed to the reduced responsiveness of peripheral blood T cells from brain tumor patients to IL-2 further to the use of corticosteroids to reduce brain inflammation [28, 48]. The gene discussed is IL2; the disease is brain inflammatory disease.